{
  "id": "5c6b7daa7c78d6947100002b",
  "type": "list",
  "question": "List major features of TEMPI Syndrome.",
  "ideal_answer": "TEMPI syndrome includes telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting. It is a newly described clinical entity that is generally considered a plasma cell dyscrasia with multiple system involvement.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25216227",
    "http://www.ncbi.nlm.nih.gov/pubmed/27501129",
    "http://www.ncbi.nlm.nih.gov/pubmed/25143825",
    "http://www.ncbi.nlm.nih.gov/pubmed/25911963",
    "http://www.ncbi.nlm.nih.gov/pubmed/30100329"
  ],
  "snippets": [
    {
      "text": "TEMPI Syndrome: Erythrocytosis in Plasma Cell Dyscrasia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30100329",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "TEMPI (telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting) syndrome is a newly described clinical entity that is generally considered a plasma cell dyscrasia with multiple system involvement. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30100329",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In other MGCS, such as scleromyxedema, Clarkson syndrome, TEMPI syndrome, cutis laxa and the neutrophilic dermatoses, the link between the monoclocal component and the entity is clearly established, but not understood so far.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27501129",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TEMPI syndrome (telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) is a recently described syndrome that, owing to erythrocytosis, may be confused with polycythemia vera.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25216227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In conclusion, TEMPI syndrome should be considered when erythrocytosis and plasma cell dyscrasia coexist.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25216227",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND\nThe TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25143825",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TEMPI syndrome is a recently described condition defined by teleangiectasias, elevated erythropoietin and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25911963",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND The TEMPI syndrome was recently described in 2011, and is characterized by the constellation of five hallmarks: Telangiectasias, Erythrocytosis and elevated Erythropoietin, Monoclonal gammopathy, Perinephric fluids collections, and Intrapulmonary shunting.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25143825",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, intrapulmonary shunting"
}